Ying S. Zou - Search Results

Year	Number of Results
2006	3
2007	2
2009	3
2010	6
2011	5
2012	2
2013	1
2014	5
2015	2
2016	1
2017	2
2018	1
2019	2
2020	1
2021	4
2022	5
2023	11
2024	5

1

Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response.

Seppälä TT, Zimmerman JW, Suri R, Zlomke H, Ivey GD, Szabolcs A, Shubert CR, Cameron JL, Burns WR, Lafaro KJ, He J, Wolfgang CL, Zou YS, Zheng L, Tuveson DA, Eshlemann JR, Ryan DP, Kimmelman AC, Hong TS, Ting DT, Jaffee EM, Burkhart RA. Seppälä TT, et al. Among authors: zou ys. Clin Cancer Res. 2022 Aug 2;28(15):3296-3307. doi: 10.1158/1078-0432.CCR-21-4165. Clin Cancer Res. 2022. PMID: 35363262 Free PMC article.

2

Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas.

Zou YS, Morsberger L, Hardy M, Ghabrial J, Stinnett V, Murry JB, Long P, Kim A, Pratilas CA, Llosa NJ, Ladle BH, Lemberg KM, Levin AS, Morris CD, Haley L, Gocke CD, Gross JM. Zou YS, et al. Genes (Basel). 2023 May 24;14(6):1139. doi: 10.3390/genes14061139. Genes (Basel). 2023. PMID: 37372318 Free PMC article.

3

Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.

Pallavajjala A, Haley L, Stinnett V, Adams E, Pallavajjala R, Huang J, Morsberger L, Hardy M, Long P, Gocke CD, Eshleman JR, Rodriguez FJ, Zou YS. Pallavajjala A, et al. Among authors: zou ys. Hum Pathol. 2022 Aug;126:63-76. doi: 10.1016/j.humpath.2022.05.001. Epub 2022 May 10. Hum Pathol. 2022. PMID: 35561840

4

EWSR1::WT1 Fusions in Neoplasms Other Than Conventional Desmoplastic Small Round Cell Tumor: Three Tumors Occurring Outside the Female Genital Tract.

Warmke LM, Perret R, Ledoux P, Michot A, Italiano A, Zou YS, Matoso A, Argani P, Ulbright TM, Baumhoer D, Ameline B, Gross JM. Warmke LM, et al. Among authors: zou ys. Mod Pathol. 2024 Mar;37(3):100418. doi: 10.1016/j.modpat.2023.100418. Epub 2023 Dec 27. Mod Pathol. 2024. PMID: 38158126

5

Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma.

Jiang L, Chen S, Stinnett V, Haley L, Morsberger L, Shane A, Hardy M, Smith K, Gocke CD, Lin MT, Zou YS. Jiang L, et al. Among authors: zou ys. Cancer Genet. 2021 Nov;258-259:18-22. doi: 10.1016/j.cancergen.2021.06.004. Epub 2021 Jun 23. Cancer Genet. 2021. PMID: 34233240

6

Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia.

Klausner M, Phan B, Morsberger L, Parish R, Shane A, Park R, Gocke CD, Xian RR, Jones RJ, Bolaños-Meade J, Gondek LP, Phan M, Zou YS. Klausner M, et al. Among authors: zou ys. Blood Cancer J. 2023 Nov 6;13(1):163. doi: 10.1038/s41408-023-00938-z. Blood Cancer J. 2023. PMID: 37926709 Free PMC article. No abstract available.

7

Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution.

Xing D, Adams E, Zou YS, Morsberger L, Scanga LR, Gao FF, Barker N, Vang R, Ronnett BM. Xing D, et al. Among authors: zou ys. Am J Surg Pathol. 2022 Sep 1;46(9):1180-1195. doi: 10.1097/PAS.0000000000001893. Epub 2022 Jul 6. Am J Surg Pathol. 2022. PMID: 35796652

8

Mechanism of delayed cell death following simultaneous CRISPR-Cas9 targeting in pancreatic cancers.

Teh SSK, Halper-Stromberg E, Morsberger L, Bennett A, Bowland K, Skaist A, Cai F, Liang H, Hruban RH, Roberts NJ, Scharpf RB, Zou YS, Eshleman JR. Teh SSK, et al. Among authors: zou ys. bioRxiv [Preprint]. 2023 Apr 5:2023.04.03.535384. doi: 10.1101/2023.04.03.535384. bioRxiv. 2023. PMID: 37066222 Free PMC article. Preprint.

9

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry.

Morsberger L, Pallavajjala A, Long P, Hardy M, Park R, Parish R, Nozari A, Zou YS. Morsberger L, et al. Among authors: zou ys. Cancer Cell Int. 2022 Nov 15;22(1):350. doi: 10.1186/s12935-022-02761-1. Cancer Cell Int. 2022. PMID: 36376842 Free PMC article.

10

A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping.

Zou YS, Klausner M, Ghabrial J, Stinnett V, Long P, Morsberger L, Murry JB, Beierl K, Gocke CD, Xian RR, Toomer KH, Ye JC, Orlowski RZ, Huff CA, Ali SA, Imus PH, Gocke CB, Tang G. Zou YS, et al. Blood Cancer J. 2024 May 3;14(1):78. doi: 10.1038/s41408-024-01059-x. Blood Cancer J. 2024. PMID: 38702349 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year